Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose vs Standard Dose Vitamin D2 with Docetaxel in Metastatic Breast Cancer
NCT00944424Phase 3Unknown
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Jul 2009
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 3
01
Overview
A Phase 3 trial of vitamin d in breast cancer, sponsored by King Faisal Specialist Hospital and Research Centre. Status: unknown.
02
Drugs
vitamin d
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00944424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944424.